Daily dose of aspirin significant lowers cancer risk

the ONA take:

In a study published in Annals of Oncology, researchers found that by taking a daily aspirin, the incidence of gastrointestinal cancers is reduced, as well as a reduction in cancer-specific mortality. For those taking a daily high-dose aspirin, their incidence of colorectal cancer was cut by 37, while those taking a low-dose aspirin saw a 25% reduction in colorectal cancer incidence. For patients diagnosed with colorectal cancer, daily aspirin reduced the rate of mortality by 40-52%.

In patients diagnosed with esophageal cancer, researchers found a 44-58% reduction in esophageal cancer-specific mortality, while daily aspirin lowered the incidence of esophageal cancer by 27-43%. Likewise, mortality caused by stomach cancer was reduced by 31-41% and an incidence reduction of 25-39%. Researchers found no significant effect of daily aspirin on the mortality or incidence of lung, prostate, or pancreatic cancer.

Aspirin lowers the risk of forming clots in the blood vessels to help prevent heart attacks and stroke, but also causes an increased risk of bleeding and rarely a hemorrhagic stroke. Despite the risk, the researchers suggest that the benefits of decreased cancer-specific mortality and incidence of cancer outweigh the potential adverse effects.

Daily dose of aspirin significant lowers cancer risk

Taking a small daily dose of aspirin can significantly reduce the risk of developing - or dying from - bowel, stomach and oesophageal cancer, according to a large review of scientific studies. Researchers who analyzed all available evidence from studies.

Researchers who analyzed all available evidence from studies and clinical trials assessing benefits and harm found that taking aspirin for 10 years could cut bowel cancer cases by around 35 percent and deaths from the disease by 40 percent.